Clinical trial
Apremilast for Alcohol Use Disorder Treatment in Women and Men
NCT06324435 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apremilast for Alcohol Use Disorder Treatment in Women and Men
- Lead sponsor
- Yale University
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- May 8, 2024
- Completion date
- August 30, 2026
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol use disorder